MC1475A1 - Procede de preparation de derives de la purine a action anti-virale - Google Patents

Procede de preparation de derives de la purine a action anti-virale

Info

Publication number
MC1475A1
MC1475A1 MC821601A MC1601A MC1475A1 MC 1475 A1 MC1475 A1 MC 1475A1 MC 821601 A MC821601 A MC 821601A MC 1601 A MC1601 A MC 1601A MC 1475 A1 MC1475 A1 MC 1475A1
Authority
MC
Monaco
Prior art keywords
group
compound
formula
transformed
salt
Prior art date
Application number
MC821601A
Other languages
English (en)
French (fr)
Inventor
Howard John Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1475A1 publication Critical patent/MC1475A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
MC821601A 1981-08-11 1982-08-10 Procede de preparation de derives de la purine a action anti-virale MC1475A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8124444 1981-08-11

Publications (1)

Publication Number Publication Date
MC1475A1 true MC1475A1 (fr) 1983-06-17

Family

ID=10523843

Family Applications (1)

Application Number Title Priority Date Filing Date
MC821601A MC1475A1 (fr) 1981-08-11 1982-08-10 Procede de preparation de derives de la purine a action anti-virale

Country Status (25)

Country Link
EP (1) EP0072027B1 (enExample)
JP (1) JPS5841879A (enExample)
KR (1) KR880002276B1 (enExample)
AT (2) AT380252B (enExample)
AU (1) AU569462B2 (enExample)
CA (1) CA1305138C (enExample)
CS (1) CS594082A2 (enExample)
DD (1) DD202717A5 (enExample)
DE (1) DE3278501D1 (enExample)
DK (1) DK154561C (enExample)
ES (3) ES8403128A1 (enExample)
FI (1) FI76086C (enExample)
GB (1) GB2104070B (enExample)
GR (1) GR76891B (enExample)
HU (1) HU189609B (enExample)
IE (1) IE54148B1 (enExample)
MC (1) MC1475A1 (enExample)
NO (1) NO158539C (enExample)
NZ (1) NZ201547A (enExample)
PH (3) PH19940A (enExample)
PL (3) PL141198B1 (enExample)
PT (1) PT75406B (enExample)
ZA (1) ZA825792B (enExample)
ZM (1) ZM6082A1 (enExample)
ZW (1) ZW16882A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
ZA83626B (en) * 1982-02-01 1983-12-28 Syntex Inc Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
US5684153A (en) * 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
AU577303B2 (en) * 1983-08-18 1988-09-22 Novartis International Pharmaceutical Ltd 9-substituted-2-amino purines
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
DE3571810D1 (en) * 1984-01-26 1989-08-31 Merck & Co Inc Substituted butyl guanines and their utilization in antiviral compositions
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
WO1986000901A1 (en) * 1984-07-20 1986-02-13 Gauntt Charles O Immunoregulatory and anti-viral compound
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3667058D1 (en) 1985-05-02 1989-12-28 Wellcome Found Antiviral compounds
DE3627024A1 (de) 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5043339A (en) * 1988-12-19 1991-08-27 Burroughs Wellcome Co. Antiviral compounds
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
DE4020481A1 (de) * 1990-06-27 1992-01-02 Hoechst Ag Verfahren zur herstellung von substituierten acyclischen nukleosiden und dabei auftretende zwischenprodukte
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
CA2152863A1 (en) * 1994-07-26 1996-01-27 Yeun-Kwei Han Preparation of acyclovir
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5559114A (en) * 1994-12-16 1996-09-24 Exley; Ray W. Treatment of autoimmune disease using 2-amino purine derivatives
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent

Also Published As

Publication number Publication date
CA1305138C (en) 1992-07-14
ES521550A0 (es) 1985-04-16
NO822725L (no) 1983-02-14
PL141281B1 (en) 1987-07-31
PH19940A (en) 1986-08-14
CS594082A2 (en) 1989-08-14
IE821921L (en) 1983-02-11
ES514877A0 (es) 1983-10-01
NZ201547A (en) 1986-01-24
EP0072027B1 (en) 1988-05-18
DK154561C (da) 1989-04-24
PT75406B (en) 1985-11-15
ES8504802A1 (es) 1985-04-16
ES521551A0 (es) 1984-12-16
NO158539C (no) 1988-09-28
PL141198B1 (en) 1987-07-31
PL247393A1 (en) 1984-10-22
JPS5841879A (ja) 1983-03-11
GB2104070A (en) 1983-03-02
JPH04989B2 (enExample) 1992-01-09
ZA825792B (en) 1984-03-28
DK154561B (da) 1988-11-28
FI76086B (fi) 1988-05-31
IE54148B1 (en) 1989-07-05
FI76086C (fi) 1988-09-09
DK359082A (da) 1983-02-12
AU8702082A (en) 1983-05-05
ATA306082A (de) 1985-09-15
NO158539B (no) 1988-06-20
HU189609B (en) 1986-07-28
PH18814A (en) 1985-09-27
FI822783L (fi) 1983-02-12
PT75406A (en) 1982-09-01
EP0072027A1 (en) 1983-02-16
PH20148A (en) 1986-10-08
DD202717A5 (de) 1983-09-28
ATE34393T1 (de) 1988-06-15
ES8502117A1 (es) 1984-12-16
ZM6082A1 (en) 1984-04-23
AU569462B2 (en) 1988-02-04
KR840001169A (ko) 1984-03-28
ZW16882A1 (en) 1984-03-14
GB2104070B (en) 1985-08-14
PL237847A1 (en) 1984-09-10
GR76891B (enExample) 1984-09-04
KR880002276B1 (ko) 1988-10-21
PL247394A1 (en) 1984-10-22
DE3278501D1 (en) 1988-06-23
ES8403128A1 (es) 1983-10-01
FI822783A0 (fi) 1982-08-10
AT380252B (de) 1986-05-12

Similar Documents

Publication Publication Date Title
MC1475A1 (fr) Procede de preparation de derives de la purine a action anti-virale
KR890004663B1 (ko) 9-(1,3-디하이드록시-2-프로폭시메틸)-구아닌 및 그의 제조방법
JP2543822B2 (ja) グアニン誘導体
FI74468C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminopurinderivat.
MC1882A1 (fr) Composes anti-viraux
MC1968A1 (fr) Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant
MC1935A1 (fr) Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant
MC1068A1 (fr) Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent
JPS647997B2 (enExample)
EP0557404B1 (fr) UTILISATION ANTIVIRALE DE COMPOSE 2,6-DI-t-BUTYLPHENOL SUBSTITUE EN POSITION 4, NOTAMMENT VIS-A-VIS DES VIRUS DE L'HERPES ET DES PAPILLOMAVIRUS
FR2498601A1 (fr) Nouveaux chromannes substitues utiles notamment comme anti-inflammatoires
EP0379412B1 (fr) Dérivés de benzonaphtyridine-1,8 leur préparation et les compositions qui les contiennent
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
CH642358A5 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant.
FR2531962A1 (fr) Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
EP0041410B1 (fr) Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
FR2574407A1 (fr) Nouveaux derives de la pyrrolo(2,3-d) pyrimidine, leur preparation et les compositions pharmaceutiques qui les contiennent
CH630629A5 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament.
EP0536035A1 (fr) Dérivés de benzonaphtyridine-1,8 et compositions anti-microbiennes
DE2708828A1 (de) Purine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen
EP0008259A1 (fr) Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0021991B1 (fr) Dérivés de la cystamine, leur préparation et compositions pharmaceutiques les contenant
EP0379413B1 (fr) Dérivés de benzonaphtyridine-1,8, leur préparation et les compositions qui les contiennent
EP0233800A1 (fr) Dérivés d'imidazo[1,2-a]quinoléines, leur préparation et leur application en thérapeutique
EP0337885A1 (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
YP Annual fee paid